TTFields

DEVICE9 trials

Sponsors

NovoCure Ltd., Juergen Debus, NovoCure GmbH, Sun Yat-sen University, Zhongnan Hospital

Conditions

GlioblastomaGlioblastoma MultiformeGliomaLocally Advanced Pancreatic AdenocarcinomaNewly Diagnosed Glioblastoma in Patients ≥70 YearsPleural MesotheliomaRecurrent Glioblastoma Multiforme

Phase 2

Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM

CompletedNCT04492163

NovoCure GmbHGlioblastoma Multiforme

Start: 2020-07-14End: 2023-06-20Updated: 2024-08-16

Unknown Phase

TTFields In GErmany in Routine Clinical Care

NovoCure Ltd.Glioblastoma

Start: 2017-08-31End: 2021-07-31Updated: 2021-01-28

Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation

WithdrawnNCT04218019

Juergen DebusNewly Diagnosed Glioblastoma in Patients ≥70 Years

Start: 2023-08-01End: 2023-08-01Updated: 2024-01-05

A Prospective, Open-label, Single-arm Clinical Study

Sun Yat-sen UniversityRecurrent Glioblastoma Multiforme

Start: 2020-04-01End: 2022-07-01Target: 40Updated: 2020-12-30

TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study

NovoCure Ltd.Glioblastoma

Start: 2021-12-30End: 2025-02-01Target: 500Updated: 2023-01-10

Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma

Zhongnan HospitalGlioblastoma, Glioma

Start: 2021-06-19End: 2022-07-19Target: 30Updated: 2021-05-26

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

RecruitingNCT05538806

NovoCure Ltd.Pleural Mesothelioma

Start: 2023-08-01End: 2028-06-30Target: 198Updated: 2025-08-22

Preoperative Preradiotherapy TTFields

RecruitingNCT06136611

The Christie NHS Foundation TrustGlioblastoma

Start: 2024-12-19End: 2026-12-30Target: 42Updated: 2026-05-08

Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)

NovoCure GmbHLocally Advanced Pancreatic Adenocarcinoma

Updated: 2026-01-06

Related Papers

Tumor Treating Fields (TTFields) Therapy in Unresectable Pleural Mesothelioma: Overview of Efficacy, Safety, and Future Outlook.

2025-04-23

CTNI-05. A PROSPECTIVE STUDY OF TUMOR-TREATING FIELDS COMBINED WITH SYSTEMIC THERAPY IN RECURRENT GLIOBLASTOMA

Neuro-Oncology2024-11-01

P27.27.A TUMOR TREATING FIELDS (TTFIELDS) THERAPY IN PATIENTS WITH GLIOBLASTOMA: LONG-TERM SURVIVAL RESULTS FROM TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER) STUDY

Neuro-Oncology2024-10-01

P14.04.A A PROSPECTIVE STUDY OF TUMOR-TREATING FIELDS COMBINED WITH SYSTEMIC THERAPY IN RECURRENT GLIOBLASTOMA

Neuro-Oncology2024-10-01

Tumor treating fields (TTFields) therapy in patients with glioblastoma: Long-term survival results from TTFields in Germany in routine clinical care (TIGER) study.

Journal of Clinical Oncology2024-06-016 citations

INNV-17. TREATMENT DECISION AND QUALITY OF LIFE OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA RECEIVING TUMOR TREATING FIELDS (TTFIELDS) THERAPY IN ROUTINE CLINICAL CARE: RESULTS FROM THE TIGER STUDY

Neuro-Oncology2023-11-01

P17.05.A TUMOR-TREATING FIELDS COMBINED WITH SECOND-LINE CHEMOTHERAPY REACHED PROGRESSION FREE SURVIVAL OF 8.33 MONTHS IN CHINESE RECURRENT GLIOBLASTOMA

Neuro-Oncology2023-09-011 citations

Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.

2023-01-0112 citations

NCOG-22. TIGER PRO-ACTIVE STUDY: INVESTIGATING DAILY ACTIVITY, SLEEP AND NEUROCOGNITIVE FUNCTIONING IN GLIOBLASTOMA PATIENTS APPLYING TTFIELDS THERAPY IN GERMANY IN ROUTINE CLINICAL CARE

Neuro-Oncology2022-11-012 citations

QOLP-31. QUALITY OF LIFE OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA DURING TTFIELDS THERAPY IN ROUTINE CLINICAL CARE: FIRST RESULTS OF THE TIGER STUDY

Neuro-Oncology2021-11-023 citations

P14.20 Quality of life of patients with newly diagnosed glioblastoma during TTFields therapy in routine clinical care: first results of the TIGER study

Neuro-Oncology2021-09-01

CTNI-71. TTFIELDS IN ROUTINE CLINICAL CARE OF NEWLY DIAGNOSED GBM PATIENTS IN GERMANY – FIRST REPORT ON THE FULLY ENROLLED TIGER STUDY POPULATION

Neuro-Oncology2020-11-01

ACTR-31. THE USE OF TTFIELDS FOR NEWLY DIAGNOSED GBM PATIENTS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER: TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE)

Neuro-Oncology2019-11-014 citations

P14.63 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care)

Neuro-Oncology2019-08-011 citations

P01.095 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care)

Neuro-Oncology2018-09-011 citations